2. Quality and Outcomes Framework: new NICE recommendations
|
|
- Thomasine Harmon
- 5 years ago
- Views:
Transcription
1 Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up to 1% for GPs and practice staff, in particular, to allow for pay increases for lower paid employed staff, in line with public sector pay policy for 2013/14 and a margin of 0.5% for increases in non-staff expenses. The proposal is to apply 1% to the Global Sum (weighted) and any savings offset against the correction factor and recycled. It is proposed to apply 0.5% to the Global Sum Equivalent (which includes the correction factor). The Welsh Government will be mindful of DDRB recommendations on GP pay and expenses should their recommendations be in excess of 1.5%. Although not part of the GMS Contract negotiations, it is also proposed (in line with England) to transfer the responsibility for paying locum superannuation payments to GP contractors to pay. The intention would be for the monies currently held by Health Boards to be applied to the Global Sum Equivalent (weighted). 2. Quality and Outcomes Framework: new NICE recommendations It is proposed to implement the majority of NICE recommendations for improvements to patient care. The NICE recommendations include improved care for patients with rheumatoid arthritis, diabetes, hypertension, chronic obstructive pulmonary disease, heart failure together with improved support for cancer patients. Details of the proposed new and replacement indicators recommended by NICE are outlined in Annex 1. The proposals address concerns about workload and loss of income as follows: (a) It is proposed not to implement the Hypertension recommendations NM36 and NM37. The introduction of these indictors will be assessed for 2014/15. The existing requirement for physical activity under existing PP2 will remain for 2013/14. (b) It is proposed the thresholds be retained at the 2012/13 level (45% - 80%) for the Hypertension recommendations NM 53 and NM 54 which replaces BP5. (c) The Diabetes Mellitus recommendations NM 27, the COPD recommendation NM 47 and the Heart Failure recommendation NM 48 are predicated on a record of referral to either a structured education programme within 9 months of entry on to the diabetes register; a record of an offer of referral to a pulmonary rehabilitation programme; offer of referral for an exercised based programme. Where these programmes of care are not available in the Health Board GP practices will not suffer a loss of income. 1
2 Guidance will be issued to Health Boards asking them to make the required QOF payment if their programmes of care are not available. (d) In relation to Diabetes Mellitus NM 28, it is proposed guidance is developed to define competency including the scope for a practice nurse to deliver this review. The new and replacement indicators will be partly funded by accepting NICE recommendations for retiring indicators from the Clinical Domain and partly by retirements of indicators from the Organisational Domain. 3. Quality and Outcomes Framework: new lower and upper payment thresholds for 20 indicators Current QOF achievement (based on 2011/12 QOF data) is significantly above the current 2012/13 threshold. In order to retain financial incentive and to encourage improvements in the quality of care, increases to the 2012/13 thresholds are proposed. In setting a new payment threshold concerns about a disproportionate workload required to achieve the additional points in reaching a new upper threshold have been considered. It is recognised a disproportionate workload in treating the most hard to reach patients will also have an opportunity cost in terms of patient care. In order to alleviate the potential for a disproportionate workload, it is proposed the new upper threshold be set at the (median) 50 th centile achievement based on 2011/12 QOF data with the new lower threshold being set at 40 percentage points below the new upper threshold. However, where the new lower threshold is lower than the existing 2012/13 threshold, it is proposed the new lower threshold for 2013/14 be retained at the 2012/13 level. Details of the proposed increase in thresholds are outlined in Annex 2. Setting the new thresholds at the 50 th centile will result in an average 10.8% increase in the upper threshold levels across the 20 indicators and an average 9.1% increase in lower threshold level across the 20 indicators. I can also confirm we are not intending to automatically uplift payment thresholds each year, or each time practices manage to achieve new thresholds. Instead, any proposed increase to thresholds will be based on a careful consideration of workload implications and the potential impact on patient care. The raising of payment thresholds for the remaining fraction indicators will be assessed through the contract negotiations for 2014/ Quality and Outcomes Framework: Organisational Domain The proposed changes to the QOF Organisational Domain are outlined in Annex 3. It is proposed indicators worth 78.5 points which require compliance through either recognised standards of good medical practice or good business practice are discontinued. It is proposed that the 78.5 points to be released 2
3 are used to fund the new QOF NICE requirements [31 points] and a new QOF QP indicator [47.5 points] aimed at improving the care for patients who suffer from a chronic condition and who are predicted to be at significant financial risk of unscheduled admission or unscheduled care. In addition, it is proposed that indicators worth 17 points are transferred to the new Public Health Domain. In relation to the 78.5 points which are proposed to be discontinued, it will be assumed GP practices will continue to meet the requirements of the indicators without financial incentive. We will be discussing with Healthcare Inspectorate Wales (HIW) a general programme of inspection in relation to primary care and the potential for appropriate validation work to be undertaken from 2014/15. Whilst we would not expect work to be undertaken on an annual basis, the final decision on the scope and frequency of any validation work will be determined by HIW. It is proposed to retain indicators worth 59 points. These indicators have a clinical and patient safety focus. It is proposed to retain the current Patient Experience Domain. 5. Quality and Outcomes Framework: Quality and Productivity Domain The proposed changes to the QOF Quality and Productivity Domain are outlined in Annex 4. It is proposed discontinuing QP12, 13,and 14 Accident and Emergency Attendances [ worth 31 points] given the potential overlap with the proposed new indicator for patients who are suffer from a chronic condition and who predicted to be a significant risk of unscheduled hospital admission or unscheduled care. It is proposed the 31 points are applied to Global Sum Equivalent (weighted). It is proposed to introduce a new QP indicator [QP 15, 16,17and 18] for patients who have a chronic condition and who predicted to be a significant risk of unscheduled hospital admission or unscheduled care. The new indicator, worth 47.5 points, is funded from discontinued Organisational Domain indicators. Concerns about the prevalence of chronic conditions in Wales have been addressed through the proposal for a maximum of 0.5% of the practice list to be applied for QP16. The guidance for this the new indicator is currently being drafted and will provide clarity on a number of practical points including the number of meetings to be held with multidisciplinary professionals. 6. Quality and Outcomes Framework: A new Public Health Domain It is proposed a new Public Health Domain will apply to Wales in line with national proposals. The proposals, broadly, involve moving indicators (worth approximately 15% of current QOF points) which are related to public health into a new Public Health Domain. The Public Health Domain would continue 3
4 to operate as an integral part of QOF within the GP contract. The priorities for the Public Health Domain would from April 2013, will be decided by PHE, in consultation with the Devolved Administrations 7. Quality and Outcomes Framework: Review dates No changes to the QOF review dates are proposed. The decision not to implement the proposed changes to the QOF review dates reflects GPs workload concerns and the potential impact on GP access. Although there is no evidence of clustering of activity in the last quarter of a financial year concerns expressed about duplication of payment will be addressed through proposed post payment verification checks which will be undertaken by NHS Wales Shared Services Partnership Wales. In addition, it is proposed Health Boards will be asked to monitor the time elapsed between the first and second review as part of their QOF validation work and to consider the impact of exception reporting using a general exception code. Note however, the decision not to implement the QOF review dates changes will be dependent on the capacity for software suppliers to apply different business rules for Wales within required timescales and reasonable costs. 8. Consideration of the need to reduce the variability of funding between GP practices The Welsh Government and GPC Wales agree there is a need to consider reducing the variability of funding between GP practices and that the funding requirements for some practices, in particular, GP practices with multiple sites, rural practices and small GP practices may not be best met through the current allocation formula. In order to address the variation of funding between GP practices, work will be undertaken in 2013/14 involving the Welsh Government, Health Boards and GPC Wales, to consider the scope for introducing changes to practice funding which recognises the different size and location of GP practices and variation in patient weighted funding. Any agreed changes to practice funding will need to be introduced over an agreed timescale, be transparent and be modelled at an individual practice level and must ensure practice financial viability together with providing on-going high quality primary care. There is recognition there may be a situation with extreme outliers that cannot be resolved within a national allocation formula and may need alternative nationally negotiated solutions. 9. Adjustment to the Contractor Population Index (CPI) It is proposed to amend the anomaly in relation to the Contractor Population Index (CPI) by basing the Index on the actual practice size list at the start of the financial quarter before the financial year in question. The intention is to undertake the index rebasing annually and to revalue QOF points. 4
5 Annex 1 Proposed New Indicators Area ID Indicator wording Thresholds Points Diabetes Mellitus NM27 The percentage of patients newly diagnosed with diabetes in the preceding 1 April to 31 March who have a record of being referred to a structured education programme within 9 months of entry on to the Diabetes Mellitus NM28 diabetes register The percentage of patients with diabetes who have a record of a dietary review by a suitably competent professional in the preceding 15 months COPD NM47 The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea Scale 3 at any time in the preceding 15 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme Heart Failure NM48 Diabetes Mellitus Diabetes Mellitus Rheumatoid Arthritis Rheumatoid Arthritis NM51 NM52 NM55 NM56 The percentage of patients with heart failure diagnosed within the preceding 15 months with a record of an offer of referral for an exercise based rehabilitation programme The percentage of male patients with diabetes with a record of being asked about erectile dysfunction in the preceding 15 months The percentage of male patients with diabetes who have a record of erectile dysfunction with a record of advice and assessment of contributory factors and treatment options in the preceding 15 months The practice can produce a register of all patients aged 16 years and over with rheumatoid arthritis The percentage of patients with rheumatoid arthritis aged years who have had a cardiovascular risk assessment using a CVD risk assessment tool adjusted for RA in the preceding 15 months N/A
6 Rheumatoid Arthritis Rheumatoid Arthritis NM57 The percentage of patients aged years with rheumatoid arthritis who have had an assessment of fracture risk using a risk assessment tool adjusted for RA in the preceding 27 months NM58 The percentage of patients with rheumatoid arthritis who have had a face to face annual review in the preceding 15 months COPD NM63 The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea Scale 3 at any time in the preceding 15 months, with a record of oxygen saturation value within the preceding 15 months Total points new indicators points Proposed Replacement Indicators Area ID Replacing Indicator wording Threshold Points CVD Primary NM26 PP1 In patients with a new Prevention diagnosis of hypertension aged years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, diabetes, stroke and/or TIA), who have a recorded CVD risk assessment score (using an agreed risk assessment tool) of 20% in the preceding 15 months: the percentage who are currently treated with statins (unless there is a contraindication) Depression NM49 DEP 1&6 The percentage of patients with a new diagnosis of depression in the preceding 1st April to
7 31st March who have had a bio-psychosocial assessment by the point of diagnosis Depression NM50 DEP 7 The percentage of patients with a new diagnosis of depression (in the preceding 1 April to 31 March) who have been reviewed within days of the date of diagnosis Hypertension NM53 BP5 The percentage of patients under 80 years old with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 140/90 or less Hypertension NM54 BP5 The percentage of patients with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 150/90 or less Diabetes Mellitus NM59 DM13 The percentage of patients with diabetes who have a record of a urine albumin:creatinine ratio test in the preceding 15 months Stroke NM60 Stroke 8 The percentage of patients with a stroke shown to be nonhaemorrhagic, or a history of TIA whose last measured total cholesterol (measured in the preceding 15 months) is 5mmol/l or less Blood pressure NM61 Records 11& 17 The percentage of patients aged 40 years and over with a blood
8 pressure measurement recorded in the preceding 5 years Cancer NM62 Cancer 3 The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the practice receiving confirmation of the diagnosis Diabetes Mellitus CVD Primary Prevention NA DM15 The percentage of patients with diabetes with a diagnosis of nephropathy (clinical proteinuria) or microalbuminuria who are treated with ACE inhibitors (or A2 antagonists) NA CVD PP2 The percentage of people diagnosed with hypertension (diagnosed after 1 April 2009) who are given lifestyle advice in the preceding 15 months for: smoking cessation, safe alcohol consumption and healthy diet Mental Health NA MH10 The percentage of patients on the register who have a comprehensive care plan documented in the preceding 15 months agreed between individuals, their family and/or carers as appropriate Total Points replacement indicators 139 Total number of Points required for new and replacement indicators 196 8
9 Points released by retirements Retirements due to replacement QOF ID 12/13 Points NICE indicator wording NM26 replaces PP1 8 In those patients with a new diagnosis of hypertension aged years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, diabetes, stroke and/or TIA), who have a recorded CVD risk assessment score (using an agreed risk assessment tool) of 20% in the preceding 15 months: the percentage who are currently treated with NM45 replaces Cancer 3 statins (unless there is a contraindication) 6 The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the practice receiving confirmation of the diagnosis DEP 1 6 The percentage of patients on the diabetes register and/or the CHD register for whom case finding for depression has been undertaken on 1 occasion during the preceding 15 months using two standard screening questions NM49 replaces DEP6 NM50 replaces DEP7 NM53 replaces BP5 NM54 replaces BP5 NM59 replaces DM13 NM60 replaces Stroke 8 NM61 replaces Records 11 NM61 replaces Records The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have had a bio-psychosocial assessment by the point of diagnosis 8 The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have been reviewed within days of the date of diagnosis 55 The percentage of patients under 80 years old with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 140/90 or less The percentage of patients with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 150/90 or less 3 The percentage of patients with diabetes who have a record of an albumin:creatinine ratio (ACR) test in the preceding 15 months 5 The percentage of patients with a stroke shown to be non- haemorrhagic, or a history of TIA whose last measured total cholesterol (measured in the preceding 15 months) is 5mmol/l or less 10 The percentage of patients aged 40 years and over with a blood pressure measurement recorded in the preceding 5 years 5 9
10 DM15 3 The percentage of patients with diabetes with a diagnosis of nephropathy (clinical proteinuria) or microalbuminuria who are treated with ACE inhibitors (or A2 antagonists) CVD PP2 5 The percentage of people diagnosed with hypertension (diagnosed after 1 April 2009) who are given lifestyle advice in the preceding 15 months for: smoking cessation, safe alcohol consumption and healthy diet MH 10 6 The percentage of patients on the register who have a comprehensive care plan documented in the preceding 15 months agreed between individuals, their family and/or carers as appropriate Total 137 Retirements QOF ID 12/13 Points Indicator Wording CHD10 7 The percentage of patients with coronary heart disease who are currently treated with a beta-blocker CKD2 4 The percentage of patients on the CKD register whose notes have a record of blood pressure in the preceding 15 months DM10 3 The percentage of patients with diabetes with a record of neuropathy testing in the preceding 15 months DM2 1 The percentage of patients with diabetes whose notes record BMI in the preceding 15 months DM22 1 The percentage of patients with diabetes who have a record of estimated glomerular filtration rate (egfr) or serum creatinine testing in the preceding 15 months EPILEPSY 6 4 The percentage of patients aged 18 years and over on drug treatment for epilepsy who have a record of seizure frequency in the preceding 15 months BP4 8 The percentage of patients with hypertension in whom there is a record of the blood pressure in the preceding nine months Total 28 NICE recommendations for QOF: point calculations Points Points required for new indicators 57 Points required for replacement indicators 139 Total points required 196 Points available from retirements due to replacement 137 Points available from retirements 28 Total points available from clinical domain 165 Points required from organisational domain 31 10
11 Annex 2 Proposed Increases in Thresholds for 2013/14 ID in UEA research ID 2011/12 ID 2012/13 ID 2013/14 Existing 2012/13 thresholds Proposed 2013/14 thresholds lower upper lower upper CHD6 CHD6 CHD6 CHD CHD8 CHD8 CHD8 CHD CHD9 CHD9 CHD9 CHD CHD12 CHD12 CHD12 CHD CHD CHD14 CHD14 CHD /11 STROKE1 STROKE1 STROKE STIA STROKE9 STROKE1 STROKE1 / STIA *BP5 BP5 BP5 HYP DM15 DM15 DM15 DM DM18 DM18 DM18 DM DM6/7 DM26 DM26 DM DM6/7 DM27 DM27 DM DM6/7 DM28 DM28 DM DM12 DM30 DM30 DM DM12 DM31 DM31 DM COPD8 COPD8 COPD8 COPD LVD3 HF3 HF3 HF CKD3 CKD3 CKD3 CKD AF3 AF3 AF6 AF SMOKE2 SMOKE4 SMOKE6 SMOK * Note : The BP 5 indicator relates to NM 54 (150/90 bps ) The payment threshold for both NM 53 and NM 54 are maintained at 2012/13 levels ( 45/80 ) 11
12 Annex 3 Proposed changes to the QOF Organisational Domain Indicators to be discontinued Points R8 Recording drug allergies / adverse reactions in the notes 1 R9 Identification of repeat medicines in records 4 R19 80% of new patients have up to date clinical summaries within 8 7 weeks R20 Up to date clinical summaries for 70% of records 12 E8 Practice employed nurses have Personal Learning Plans and 5 subject to annual appraisals E9 Practice employed non clinical team members have an annual 3 appraisal PM2 Arrangements in place to back up computer data 1 PM3 The Hep B status for doctors and relevant practice staff is recorded 0.5 and immunisation recommended if required PM7 System to ensure regular inspection of equipment. 3 PM10 Written procedure manual covering employment policy 2 E1 Record of practice staff attending life support training in the 4 preceding 18 months E5 Record of practice staff attending life support training in the 3 preceding and 36 months R15 Up to date clinical summaries for 60% of records 25 R18 Up to date clinical summaries for 80% of records 8 Total points discontinued 78.5 Indicators to be transferred to the Public Health Domain Points R11 R17 I 5 Blood pressure of patients aged 45 years and over is recorded in 10 the preceding 5 years for at least 65% of patients Blood pressure of patients aged 45 years and over is recorded in 5 the preceding 5 years for at least 80% of patients Practice supports smokers in stopping smoking by a strategy which 2 includes providing literature and offering appropriate therapy. Total points transferred to the Public Health Domain 17 Indicators to be retained Points R3 System for transferring / acting on information about patients seen 1 by other doctors OOH R13 System to alert OOH services / doctor to patients dying at home 2 E6 Practice conducts annual review of patient complaints 3 E7 12 significant reviews undertaken in last 3 years 4 E10 Practice has undertaken at least 3 significant event reviews within the last year 6 12
13 PM5 Minimum appointment times 3 PM9 Protocol to identify carers 3 PM1 Health professionals have access to information on local 1 procedures dealing with child protection MM 2 Practice has equipment and drugs to treat anaphylaxis 2 MM 3 System for checking expiry dates of emergency drugs 2 MM4 Availability of prescription within 72 hours 3 MM6 Practice meets with PCO prescribing advisor annually and agrees 4 3 actions MM8 Collection of prescription within 48 hours 6 MM10 Practice meets with PCO prescribing advisor annually and agrees 4 3 actions and provides evidence of change MM11 Medication review is recorded in notes in preceding 15 months for 7 patients who are prescribed 4 or more repeat medicines MM12 Medication review is recorded in notes in preceding 15 months for 8 all patients who are prescribed repeat medicines Total points to be retained 59 Summary of Changes to Organisation Domain Total number of points Points discontinued : applied to fund NICE 31 Points discontinued : applied to fund new QP indicator for chronic 47.5 conditions Points transferred to Public Health Domain 17 Indicators retained 59 13
14 Proposed changes to the QOF Quality and Productivity Indicators Annex 4 Indicators to be discontinued Points QP12 Accident and Emergency Attendances - review data 7 QP13 Accident and Emergency Attendances - participate in 9 external review QP14 Accident and Emergency Attendances - implement 15 improvement plan Total points to be discontinued 31 The discontinued points to be transferred to Global Sum Equivalent (weighted) Existing indicators to be retained Points QP6 The practice meets internally to review the data on 5 secondary care outpatient referrals provided by the PCO QP7 The practice participates in an external peer review with a 5 group of practices to compare its secondary care outpatient referral data either with practices in the group of practices or with practices in the PCO area and proposes areas for commissioning or service design improvements to the PCO QP8 The practice engages with the development of and follows 3 11 agreed care pathways for improving the management of patients in the primary care setting (unless in individual cases they justify clinical reasons for not doing this) to avoid inappropriate outpatient referrals and produces a report of the action taken to the PCO no later than 31 March 2014 QP9 The practice meets internally to review the data on emergency admissions provided by the PCO 5 QP10 The practice participates in an external peer review with a 15 group of practices to compare its data on emergency admissions either with practices in the group of practices or practices in the PCO area and proposes areas for commissioning or service design improvements to the PCO QP11 The practice engages with the development of and follows agreed care pathways (unless in individual cases they justify clinical reasons for not doing this) in the management and treatment of patients in aiming to avoid emergency admissions and produces a report of the action taken to the PCO no later than 31 March 2013 Total points 68.5 Proposed new indicators QP15 The practice produces a list of 5% of patients in the practice 10 who are predicted to be at significant risk of unscheduled admission or unscheduled care. QP16 The practice identifies a minimum of 10% ( with a maximum 10 14
15 of 0.5% of the practice list ) of those patients from the list produced in indicator QP15 who would most benefit from review and ensures there is an active management plan (see template attached) in place for each patient. The active management plan must include an appropriate review date. The frequency of each patient's review should be determined in light of their clinical and care needs. The practice will be responsible for ensuring that an appropriate system is in place for monitoring and review of the patients identified QP17 The practice has at least four meetings during the year to 22.5 review the needs of the patients identified as a result of developing the active management plans, to identify learning needs and related changes in patient management. These meetings should be open to multi-disciplinary professionals who support the practice's patients. QP18 The practice reports annually to the CCG or PCO on system 5 changes that may benefit patients Total points 47.5 Points funded from discontinued Organisational Domain indicators New Total QOF QP points 116 Retained existing indicators ( 68.5 points ) and new risk profile indicators ( 47.5 points) Summary of Changes to Quality and Productivity indicators Total number of points 99.5 Points discontinued 31 New indicator : funded from Organisation Domain 47.5 Indicators retained
POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK
POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY
More informationSummary of 2012/13 QOF Changes
Summary of QOF Changes Retirements 2011/12 CHD13 AF4 QP1 QP2 QP3 QP4 QP5 2011/12 Indicator Wording Threshold For patients with newly diagnosed angina (diagnosed after 1 April 2011), the percentage who
More informationSUMMARY OF CHANGES TO QOF 2014/15 - ENGLAND CLINICAL
SUMMARY OF CHANGES TO QOF 20 - ENGLAND KEY No change Retired /or change Point or threshold change Funding transferred to enhanced services change QOF NICE CLINICAL Atrial Fibrilation (AF) AF001 AF001 -
More information14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE
SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes
More information17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE
SUMMARY OF CHANGES TO QOF 2018/19 - ENGLAND 18-19 QOF005 KEY No change Retired/replaced Wording and/or timeframe change Point or threshold change Indicator ID change 17/18 QOF ID 18/19 QOF ID NICE ID Indicator
More informationSummary of 2011/12 QOF indicator changes, points and thresholds
Summary of 2011/12 QOF indicator changes, points and thresholds Retirements 2010/11 QOF ID 2010/11 Indicator Wording Points Threshold CHD5 The percentage of patients with coronary heart disease whose notes
More informationSUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL
SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND KEY No change Retired/replaced Wording and/or timeframe change Point or threshold change Indicator ID change 1/17 QOF ID 17/18 QOF ID NICE ID Indicator wording
More informationQuality And Outcomes Framework Guidance for the GMS Contract Wales 2018/19. June 2018
Quality And Outcomes Framework Guidance for the GMS Contract Wales 018/19 June 018 Page 1 of 14 Strategic background Delivery of more care in the community and closer to home through primary care clusters
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME. Indicator Assessment Report
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Output: Advice for NHS England Assessment Report Date of QOF Advisory Committee meeting:
More informationCardiology The interface between Primary and Secondary Care
Cardiology The interface between Primary and Secondary Care Dr A Daniels GP, Cardiff South East Wales Cardiac Network The view from secondary care Referral to treatment times targets Clinics are full of
More information12/13 Threshold. 13/14 Points. 12/13 Points. Minor wording change (noted in bold) mnth change
NM0 NM NM5 NM4 NM2 NM7 NM NM5 NM48 NM07 NM4 NM45 NM24 NICE ID Summary of QOF changes for 201/14 in England KEY Retired New Replaced Wording amended /1 QOF ID AF1 AF5 1/14 QOF ID CLINICAL DOMAIN Atrial
More informationThe contractor establishes and maintains a register of patients with AF
Atrial Fibrillation The contractor establishes and maintains a register of patients with AF G5731 Those patients with AF in whom there is a record of CHADS2 score of 1, the % of patients who are currently
More informationScottish Quality and Outcomes Framework 2013/2014. Guidance for NHS Boards and GP practices
Scottish Quality and Outcomes Framework 2013/2014 Guidance for NHS Boards and GP practices 1 May 2013 1 Contents Section 1 Introduction 5 General information on indicators 6 Disease registers 8 QOF Business
More informationQuality and Outcomes Framework guidance for GMS contract 2009/10. Delivering investment in general practice
Quality and Outcomes Framework guidance for GMS contract 2009/10 Delivering investment in general practice March 2009 Contents Section 1. Principles 3 Section 2. Clinical Indicators 7 Secondary prevention
More informationRoyal Crescent Surgery
NATIONAL GENERAL PRACTICE PROFILES PROFILE FOR Royal Crescent Surgery 25 Crescent Street, Weymouth, Dorset These profiles are designed to support clinical commissioning groups (s), GPs and local authorities
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationScottish Quality and Outcomes Framework guidance for GMS contract 2015/16
2015/16 Contents Section 1: Introduction... 6 Principles... 7 General information on indicators... 7 Disease registers (denominators)... 9 Clinical areas previously transferred to core... 10 Verification...
More informationThe following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators.
Quality and outcomes framework Guidance 2006 Section 1: Principles The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators. 1 Indicators should, where
More informationQOF indicator area: Chronic Obstructive Pulmonary disease (COPD)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Chronic Obstructive Pulmonary Disease QOF indicator area:
More information2015/16 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF)
2015/16 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF) Guidance for GMS contract 2015/16 March 2015 Publications Gateway Reference Number 03099 Contents Section 1 Introduction
More informationQuality And Outcomes Framework Guidance for the GMS Contract Wales 2014/15. June 2014
Quality And Outcomes Framework Guidance for the GMS Contract Wales 2014/15 June 2014 Contents Section 1 Introduction 3 General information on indicators 4 Disease registers 6 Business rules 8 Exception
More informationVascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme
Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?
More informationQuality And Outcomes Framework Guidance for the GMS Contract Wales 2013/14. May 2013
Quality And Outcomes Framework Guidance for the GMS Contract Wales 2013/14 May 2013 Contents Section 1 Introduction 3 General information on indicators 4 Disease registers 6 Business rules 7 Exception
More informationNICE Indicator Programme. Consultation on proposed amendments to current QOF indicators
NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationQOF (England): clinical indicators
QOF 2015 16 (England): clinical indicators Here is a quick summary of the planned changes for QOF in England for 2015 16. This covers only the clinical aspects of QOF, as you might need them in the consultation,
More informationRef. No. Title Quality Dimension
Ref. No. Title Quality Dimension NSR Pathway Topic CV35 Percentage of ST-elevation myocardial infarction (STEMI) patients who received primary angioplasty within 120 minutes of call (call to balloon time)
More informationIndicator Points Payment stages. HF 1: The practice can produce a register of patients with 4 heart failure
Heart failure Indicator Points Payment stages Records HF 1: The practice can produce a register of patients with 4 heart failure Initial diagnosis HF 2: The percentage of patients with a diagnosis of heart
More informationGP Cluster Network Action Plan Upper Valleys Cluster
GP Cluster Network Action Plan 2015-16 Upper Valleys Cluster The Cluster Network 1 Development Domain supports GP Practices to work to collaborate to: Understand local health needs and priorities. Develop
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Hypertension QOF indicator area: Hypertension Date: July 2013
More informationCommissioning for value focus pack
Commissioning for value focus pack Clinical commissioning group: NHS MILTON KEYNES CCG Focus area: Cardiovascular disease (CVD) pathway Version 2 June 2014 Contents 1. Background and context About the
More informationFour Years of NHS Health Checks in Barnsley - Outcomes and Inequalities
Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Summary After four years of NHS Health Checks, Barnsley has access to aggregated data on over 47,000 people. This data was analysed
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationCosting report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
More informationTime Series Analysis for selected clinical indicators from the Quality and Outcomes Framework
Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework 21-26 Title Document Type Time Series Analysis for selected clinical indicators from the Quality and Outcomes
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationThe National Quality Standards for Chronic Kidney Disease
The National Quality Standards for Chronic Kidney Disease Dr Robert Lewis Chief of Service, Wessex Kidney Centre, Portsmouth Specialist Committee Member Quality Standard for Chronic Kidney Disease, NICE
More informationA Suite of Enhanced Services for. Prudent Structured Care for Adults with Type 2 Diabetes
An Enhanced Service for Prudent Structured Care for Adults with Type 2 Diabetes Page 1 A Suite of Enhanced Services for Prudent Structured Care for Adults with Type 2 Diabetes 1. Introduction All practices
More informationNational Chronic Kidney Disease Audit
National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: // Foreword by Fiona Loud And if, as part of good, patient-centred care, a record of your condition(s),
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationGUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0
GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0 July 2013 The following guidance discusses the effect of changes to the Quality and Outcomes Framework (QOF) for 2013-14 on
More informationEnhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641
Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641 Introduction 1. All GMS practices are expected to provide essential and those additional
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2017/18 2 Enhanced Service Specification Childhood seasonal influenza vaccination programme Version number: 1 First published:
More informationUNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator
UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator QOF indicator area: Hypertension Over 80 Potential output:
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2018/19 Contents Childhood seasonal influenza vaccination programme... 1 Contents... 4 1 Introduction... 5 2 Background...
More informationFINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY
FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY What is your view of the effects of the demographic change and an ageing population on the
More informationThe RPS is the professional body for pharmacists in Wales and across Great Britain. We are the only body that represents all sectors of pharmacy.
Royal Pharmaceutical Society 2 Ash Tree Court Woodsy Close Cardiff Gate Business Park Pontprennau Cardiff CF23 8RW Mr Mark Drakeford AM, Chair, Health and Social Care Committee National Assembly for Wales
More informationNational Primary Care Research and Development Centre and University of York Health Economics Consortium (NICE External Contractor)
National Primary Care Research and Development Centre and University of York Health Economics Consortium (NICE External Contractor) July 2010 Health economic report: threshold analysis This paper was prepared
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationGUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0. January 2014
GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0 January 2014 The following guidance discusses the effect of changes to the Quality and Outcomes Framework (QOF) for 2013-14
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
More informationShaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG
Shaping Diabetes Services in Southern Derbyshire A vision for Diabetes Services For Southern Derbyshire CCG Vanessa Vale Commissioning Manager September 2013 Contents 1. Introduction 3 2. National Guidance
More informationDirected Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups
Directed Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups October 2009 Introduction NHS Employers and the General Practitioners Committee (GPC) of the BMA have agreed arrangements
More informationGMS Contract in Wales Enhanced Service for Homeless Patients Specification
Doc 4 GMS Contract in Wales 2008-09 Enhanced Service for Homeless Patients Specification Introduction The purpose of this paper is to provide an enhanced service specification for Local Health Boards when
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationWorking with the changes to QoF 08/09
Who are Insight Solutions? Working with the changes to QoF 08/09 Training Consultant Independent Primary Care IT Training Consultancy Unique in that we can provide clinical system training across all main
More informationOutcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports
Outcomes of diabetes care in England and Wales A summary of findings from the National Diabetes Audit 2015 16: Complications and Mortality reports About this report This report is for people with diabetes
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationResource impact report: Eating disorders: recognition and treatment (NG69)
Resource impact report: Eating disorders: recognition and treatment (NG69) Published: May 2017 Summary This report looks at the resource impact of implementing NICE s guideline on eating disorders: recognition
More informationCQC Insight. NHS GP practices Indicators and methodology
CQC Insight NHS GP practices s and methodology June 2017 Contents Introduction... 3 Background information on CQC Insight reports... 4 Displaying proportions as percentages... 5 Suppression rules... 5
More informationThe Health Problem: Guidelines: NHS Priority:
PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation research project.
More informationNumber of people with diabetes
Written evidence from Diabetes UK DIABETES: THE BIGGEST HEALTH CHALLENGE OF OUR TIME A SYSTEM IN CRISIS 1. The Rising Tide of Diabetes and the Challenge for the NHS 2.1 Diabetes has become one of the biggest
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National
More informationWORKING DOCUMENT Version 5 DRAFT LOCAL ENHANCED SERVICE SPECIFICATION Palliative Care
Appendix F WORKING DOCUMENT Version 5 DRAFT LOCAL ENHANCED SERVICE SPECIFICATION Palliative Care Introduction 1. The LES has been introduced to embed good clinical practice and effective performance management
More informationThe links between physical health in mental health
The links between physical health in mental health A holistic approach to managing mental and physical health is needed. Physical and mental health are inextricably linked 1 What is the problem? It is
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationpat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16
pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE
More informationOptimising Hypertension Management Clair Huckerby Pharmaceutical Adviser- Medicines Optimisation Lead
Optimising Hypertension Management Clair Huckerby Pharmaceutical Adviser- Medicines Optimisation Lead Pharmaceutical Public Health Team The Office of Public Health and Dudley CCG Dudley - doing things
More informationEstimated number of people with hypertension. Significantly higher than the. Proportion. diagnosed with. hypertension
Hypertension profile Background Diagnosis and control of hypertension in * This profile compares with data for, authorities in the South East region and the Office for National Statistics (ONS) group of
More informationUNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator
UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator QOF indicator area: Hypertension Under 80 Potential output:
More informationHow effective are national strategies for getting evidence into practice?
How effective are national strategies for getting evidence into practice? Dr Gillian Leng Deputy Chief Executive, NICE Areas to cover Getting NICE guidance into practice Challenges National strategy Impact
More informationGP Insight Report. Oaklands CQC ID:
GP Insight Report Oaklands CQC ID: 1-542862750 1 CQC GP Insight Report June 2017 spacer Practice background > Introduction INTRODUCTION CONTEXTUAL INFORMATION This report details the CQC view of 11 Insight
More informationHealtheast CCG - developing an understanding of health and wellbeing needs. Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council
Healtheast CCG - developing an understanding of health and wellbeing needs Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council Acknowledgements Norfolk County Council Children s Services
More informationPrimary Care Commission Study Visit. 26 March 2015
Primary Care Commission Study Visit 26 March 2015 1 Agenda 1. How we got to where we are? 2. Suffolk GP Federation 3. North East Essex diabetes service 4. Working at scale issues and challenges 2 1. How
More informationRecommendations from the Devon Prisons Health Needs Assessment. HMP Exeter, HMP Channings Wood and HMP Dartmoor
from the Devon Prisons Health Needs Assessment HMP Exeter, HMP Channings Wood and HMP Dartmoor 2011-2012 In April 2006 the responsibility for prison healthcare transferred from HM Prison Service to the
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Clinical Commissioning Group (CCG) / Local Health Board (LHB) Report Summary for NHS Bristol CCG (11H) Key findings about
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Clinical Commissioning Group (CCG) / Local Health Board (LHB) Report Summary for NHS Wirral CCG (12F) Key findings about
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Report Summary for Dorset County Hospital (RBD01) Key findings about the outcomes for people with diabetes in Dorset County
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background
More informationfor adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services
The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service
More informationSouth Tyneside Exercise Referral and Weight Management Programme
South Tyneside Exercise Referral and Weight Management Programme Referral Guidance Document 2011/2012 1 2 South Tyneside Exercise Referral and Community Weight Management Programme Introduction An Exercise
More informationGuidelines for the appointment of. General Practitioners with Special Interests in the Delivery of Clinical Services. Epilepsy
Guidelines for the appointment of General Practitioners with Special Interests in the Delivery of Clinical Services Epilepsy April 2003 Epilepsy This general practitioner with special interest (GPwSI)
More informationNational Diabetes Insulin Pump Audit, England and Wales
National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)
More informationCardiff East Cluster
Network Action Plan 2016-2017 Annex 3 Cardiff East Completed by Dr R Morris with help from cluster. 1 The Network 1 Development Domain supports GP Practices to work to collaborate to: Underst local health
More informationHIGH BLOOD PRESSURE. How can we do better?
HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Diabetes dietary review Potential output: Recommendations
More informationGP Insight Report. The Family Practice CQC ID:
GP Insight Report The Family Practice CQC ID: 1-562698152 1 CQC GP Insight Report February 2017 spacer Practice background > Introduction INTRODUCTION CONTEXTUAL INFORMATION This report details the CQC
More informationTHE NATIONAL HEALTH SERVICE (PERSONAL DENTAL SERVICES AGREEMENTS) (WALES) REGULATIONS 2006
REGULATORY APPRAISAL NATIONAL HEALTH SERVICE, WALES THE NATIONAL HEALTH SERVICE (PERSONAL DENTAL SERVICES AGREEMENTS) (WALES) REGULATIONS 2006 Background 1. In the main, NHS dental care and treatment is
More informationPRESCRIBING INCENTIVE SCHEME 2018/19
PRESCRIBING INCENTIVE SCHEME 2018/19 Summary Harrogate and Rural District CCG is continuing to offer a prescribing incentive scheme to all its member NHS GP practices as encouragement and reward to improve
More informationE-portfolio guide. This guide will take you through, step by step, the type of information we expect you to record at each stage of your cycle.
E-portfolio guide The e-portfolio is designed to help you become a reflective learner and to emphasise the knowledge you are picking up on a daily basis. This guide will take you through, step by step,
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationExplanatory Memorandum to accompany the following subordinate legislation-
Explanatory Memorandum to accompany the following subordinate legislation- 1. Care Standards Act 2000 (Extension of the Application of Part 2 to Private Dental Practices) (Wales) Regulations 2017, 2. Private
More informationLipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention)
Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention) Policy Statement: October 2010 This policy defines the decision made by NHS Wirral following an evidence review
More informationThat the Single Commissioning Board supports the project outlined in this report and proceeds as described.
Report to: SINGLE COMMISSIONING BOARD Date: 26 September 2017 Officer of Single Commissioning Board Subject: Report Summary: Recommendations: Jessica Williams Interim Director of Commissioning ATRIAL FIBRILLATION
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME QOF indicator area: Epilepsy Briefing paper Potential output: Recommendations
More informationREPORT TO CLINICAL COMMISSIONING GROUP
REPORT TO CLINICAL COMMISSIONING GROUP 12th December 2012 Agenda No. 6.2 Title of Document: Report Author/s: Lead Director/ Clinical Lead: Contact details: Commissioning Model for Dementia Care Dr Aryan
More informationHypertension Profile. NHS High Weald Lewes Havens CCG. Background
NHS High Weald Lewes Havens Background Hypertension Profile Diagnosis and control of in NHS High Weald Lewes Havens * This profile compares NHS High Weald Lewes Havens with data for, a group of similar
More information